Table 4.
Benign (n = 35) | Malignant (n = 15) | p | |
---|---|---|---|
TIR3A (n = 23) | 20 (86.96%) | 3 (13.04%) | |
TIR3B (n = 27) | 15 (55.56%) | 12 (44.44%) | 0.0286 |
Benign (n = 35) | Malignant (n = 15) | p | |
---|---|---|---|
TIR3A (n = 23) | 20 (86.96%) | 3 (13.04%) | |
TIR3B (n = 27) | 15 (55.56%) | 12 (44.44%) | 0.0286 |